Page 2 - Christopher Causey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

United Therapeutics (NASDAQ:UTHR – Get Free Report) released its quarterly earnings results on Wednesday. The biotechnology company reported $4.36 earnings per share for the quarter, topping analysts’ consensus estimates of $4.28 by $0.08, MarketWatch Earnings reports. The firm had revenue of $614.70 million during the quarter, compared to analysts’ expectations of $575.01 million. United Therapeutics […]

Covestor Ltd lowered its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 812 shares of the biotechnology company’s stock after selling 362 shares during the period. Covestor Ltd’s holdings […]

Covestor Ltd reduced its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 812 shares of the biotechnology company’s stock after selling 362 shares during the period. Covestor Ltd’s holdings in […]

Covestor Ltd lowered its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 812 shares of the biotechnology company’s stock after selling 362 shares during the period. Covestor Ltd’s holdings […]

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $300.00 price target on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on the company. StockNews.com cut United Therapeutics […]